CTX-M-9 group extended-spectrum β-lactamases in neonatal stool isolates: emergence in India

S Roy1, S Mukherjee, A K Singh

  • 1Division of Bacteriology, National Institute of Cholera and Enteric Diseases, P33, CIT Road, Scheme XM, Beliaghata, Kolkata - 700 010, India.

Insights

The study identified novel extended-spectrum beta-lactamases (ESBLs) in Indian neonatal stool. These ESBL genes, belonging to the CTX-M-9 group, were transferable and may signal future infections.

Area of Science:

  • Microbiology
  • Genetics
  • Public Health

Background:

  • Extended-spectrum beta-lactamases (ESBLs) are enzymes that confer resistance to beta-lactam antibiotics.
  • The CTX-M family of ESBLs is a significant global health concern, with various groups identified.
  • Previous reports from India primarily focused on the CTX-M-1 group of ESBLs.

Observation:

  • This study investigated ESBLs in Klebsiella pneumoniae and Escherichia coli from neonatal stool samples in India.
  • CTX-M-14-like and CTX-M-27-like ESBLs, belonging to the CTX-M-9 group, were identified for the first time in these isolates.
  • The genes encoding the CTX-M-9 group ESBLs were found on transferable plasmids.

Findings:

  • A high prevalence (77%) of ESBL-producing K. pneumoniae or E. coli was detected in the neonatal stool samples.
  • The blaCTX-M-15 gene, belonging to the CTX-M-1 group, was the predominant ESBL gene identified.
  • The CTX-M-9 group ESBLs were detected in stool samples but did not appear to cause active infection in the neonates.

Implications:

  • The emergence and transferability of CTX-M-9 group ESBLs in a vulnerable neonatal population is a significant public health finding.
  • While not causing current infections, the presence of these novel ESBLs may indicate a potential for future outbreaks or infections.
  • This highlights the need for enhanced surveillance of ESBLs, particularly novel groups, in healthcare settings and the community in India.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...